These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25283153)

  • 1. Identification of the growth hormone-releasing hormone analogue [Pro1, Val14]-hGHRH with an incomplete C-term amidation in a confiscated product.
    Esposito S; Deventer K; Van Eenoo P
    Drug Test Anal; 2014; 6(11-12):1155-9. PubMed ID: 25283153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of an unknown fusion protein in confiscated black market products.
    Walpurgis K; Krug O; Thomas A; Laussmann T; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1117-24. PubMed ID: 25219942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.
    Henninge J; Pepaj M; Hullstein I; Hemmersbach P
    Drug Test Anal; 2010; 2(11-12):647-50. PubMed ID: 21204297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control analysis of selected peptide hormones using LC-MS(/MS).
    Thevis M; Thomas A; Schänzer W
    Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products.
    Esposito S; Deventer K; Van Eenoo P
    Rapid Commun Mass Spectrom; 2012 Mar; 26(6):686-92. PubMed ID: 22328223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine-modified growth hormone secretagogues identified in seized doping material.
    Gajda PM; Holm NB; Hoej LJ; Rasmussen BS; Dalsgaard PW; Reitzel LA; Linnet K
    Drug Test Anal; 2019 Feb; 11(2):350-354. PubMed ID: 30136411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of fibroblast growth factor 1 (FGF-1) in a black market product.
    Walpurgis K; Thomas A; Laussmann T; Horta L; Metzger S; Schänzer W; Thevis M
    Drug Test Anal; 2011; 3(11-12):791-7. PubMed ID: 21998075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.
    Kohler M; Thomas A; Geyer H; Petrou M; Schänzer W; Thevis M
    Drug Test Anal; 2010; 2(11-12):533-7. PubMed ID: 21204286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the constructions and activities of three novel hGHRH analogs with N-terminal prolyl modulation+.
    Tang SS; Du MH; Zhang XW; Zhang JH; Kong X; Wu J; Liu JJ
    Regul Pept; 2006 Jan; 133(1-3):20-6. PubMed ID: 16260050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
    Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
    J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and activity of a novel GHRH analog, Pro-Pro-hGHRH(1-44)-Gly-Gly-Cys.
    Tang SS; Zhang JH; Du MH; Wu J; Liu JJ
    Acta Pharmacol Sin; 2004 Nov; 25(11):1464-70. PubMed ID: 15525469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and enhanced biological activity of a novel GHRH analog, hGHRH with an N-terminal Pro-Pro extension.
    Tang SS; Chen ZL; Liu JJ
    Protein Expr Purif; 2004 Apr; 34(2):296-301. PubMed ID: 15003264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
    Thomas A; Schänzer W; Delahaut P; Thevis M
    Methods; 2012 Feb; 56(2):230-5. PubMed ID: 21871962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of enzymatic semisyntheses of peptide amides: human growth hormone releasing factor and analogs.
    Bongers J; Offord RE; Felix AM; Lambros T; Liu W; Ahmad M; Campbell RM; Heimer EP
    Biomed Biochim Acta; 1991; 50(10-11):S157-62. PubMed ID: 1820039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the chemical stability of a new growth hormone-releasing hormone (GHRH) analogue by HPLC.
    Idei M; Mezö I; Szabó EZ; Kéri G
    Biomed Chromatogr; 1996; 10(2):89-91. PubMed ID: 8924733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel structure-related hGHRH agonistic analogs.
    Zhou D; You J; Li QY; Li HZ; Wu WF; Zhang XD; Zhang JH; Tang SS; Wang YK; Liu T
    Growth Factors; 2015 Apr; 33(2):160-8. PubMed ID: 25798996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic amidation of recombinant (Leu27) growth hormone releasing hormone-Gly45.
    Engels JW; Glauder J; Müllner H; Tripier D; Uhlmann E; Wetekam W
    Protein Eng; 1987 Jun; 1(3):195-9. PubMed ID: 3148933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hGHRH analog and its comparative activity.
    Tang SS; Du MH; Zhang XW; Zhang JH; Wu J; Mahanmad E; Liu JJ
    Comb Chem High Throughput Screen; 2006 Mar; 9(3):197-202. PubMed ID: 16533153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview on performance and image enhancing drugs (PIEDs) confiscated in Italy in the period 2017-2019.
    Odoardi S; Mestria S; Biosa G; Valentini V; Federici S; Strano Rossi S
    Clin Toxicol (Phila); 2021 Jan; 59(1):47-52. PubMed ID: 32475176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report.
    Gaudiano MC; Valvo L; Borioni A
    Drug Test Anal; 2014 Mar; 6(3):295-300. PubMed ID: 24446112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.